Article
Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway
4 May 2023
Abstract excerpt
Objective To investigate the mechanism underlying the effects of berberine (BBR) in the treatment of Alzheimer’s disease (AD). Methods 3 × Tg AD mice were treated with BBR for 3 months, then the open field test (OFT), the novel object recognition test (NOR) and the Morris water maze (MWM) test were performed to assess behavioral performance. Hematoxylin–eosin (HE) staining, Nissl staining were used to examine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
